Budesonide Inhalation Suspension
Product Images NDC 68788-8429

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Budesonide Inhalation (NDC 68788-8429). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Budesonide Inhalation Suspension 0.25mg Per 2ml (1d139a25 9c17 4b3e 8ffd B2d562cc00ee 00)

Label for Budesonide Inhalation Suspension 0.25 mg/2 mL, a respiratory inhalation suspension. The label states it is a generic for Pulmicort, manufactured by Amneal Pharmaceuticals, Inc. It includes storage instructions, caution about federal law restricting drug transfer, and bilingual usage directions. The label features barcode and QR code areas.*

FDA Label Image

Chemical Structure Formula Of Budesonide (Budesonide Inhalation Suspension 1)

Chemical structure diagram of the active ingredient Budesonide, showing the molecular arrangement including rings and functional groups, associated with Budesonide Inhalation suspension.*

FDA Label Image

Figure 1: A 12-week Trial In Pediatric Patients Previously Maintained On Inhaled Corticosteroid Therapy Prior To Study Entry. Nighttime Asthma Change From Baseline (Budesonide Inhalation Suspension 2)

A line graph showing mean change from baseline in nighttime asthma symptoms over time from Baseline to Week >10-12 and Weeks 0-12. It compares three groups: Placebo, Budesonide 0.25 mg twice daily, and Budesonide 0.5 mg twice daily, with change values plotted on the vertical axis ranging from -0.6 to 0.1.*

FDA Label Image

Figure 2: A 12-week Trial In Pediatric Patients Either Maintained On Bronchodilators Alone Or Inhaled Corticosteroid Therapy Prior To Study Entry. Nighttime Asthma Change From Baseline (Budesonide Inhalation Suspension 3)

A line graph comparing mean change from baseline in nighttime asthma symptoms over 12 weeks for Budesonide Inhalation suspension at 0.25 mg twice daily and 0.5 mg twice daily doses versus placebo. The Y-axis shows mean change from baseline, and the X-axis represents time in weeks with multiple intervals from baseline to week 12. The graph displays decreasing symptoms over time for both doses compared to placebo.*

FDA Label Image

Figure 1 Open The Sealed Foil Envelope Along The Dotted Line And Take Out 1 Single-dose Ampule From The Strip. (Budesonide Inhalation Suspension 4)

Instructional illustration showing a person holding the Budesonide Inhalation suspension vial pack and using a hand to open one of the individual unit-dose vials for respiratory inhalation.*

FDA Label Image

Figure 2 Gently Shake The Budesonide Inhalation Suspension Ampule Using A Circular Motion (Budesonide Inhalation Suspension 5)

An instructional illustration showing a hand holding a vial of Budesonide Inhalation suspension, demonstrating how to twist or open the vial cap in preparation for inhalation use.*

FDA Label Image

Figure 3 Hold The Budesonide Inhalation Suspension Ampule Upright Without Squeezing The Ampule And Open By Twisting Off The Top. (Budesonide Inhalation Suspension 6)

Instructional illustration showing hands preparing a Budesonide inhalation suspension device for use, demonstrating how to handle the inhaler properly prior to administration.*

FDA Label Image

4. Place The Open End Of The Budesonide Inhalation Suspension Ampule Into The Nebulizer Cup (reservoir) And Slowly Squeeze All Of The Medicine From The Ampule Into The Nebulizer Medicine Cup As Shown In Figure 4. Throw Away The Empty Ampule. (Budesonide Inhalation Suspension 7)

An instructional illustration showing hands preparing a respiratory suspension inhalation device, with one hand holding the inhaler and the other hand pouring suspension into a measuring cup from a container.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.